Google News • 1/11/2026 – 1/13/2026
Private and public biotechs have raised $4.9 billion in funding ahead of the JPM conference. Parabilis Medicines has secured $305 million to advance its cancer drug and is considering an IPO.
Advertisement
Stories gain Lindy status through source reputation, network consensus, and time survival.

